In Q1 2025, the Baird Chautauqua International Growth Fund Net Investor Class returned +5.01%, underperforming its benchmark ...

Article originally published by. FE fundinfo is not responsible for its content or accuracy and may not share the author’s views. News and research are not personal recommendations to deal. All ...

Novo Nordisk (NVO) stock in focus as the company promotes FDA-approved Wegovy as a ban for makers of compounding versions ...

Over the past six months, Eli Lilly has earned significant wins over its Denmark-based rival and is still at it. Recent clinical trial results Eli Lilly released suggest that it is building a lead in ...

Novo Nordisk reduces its starter dose prices through telehealth platforms to encourage weaning patients off compounded copycats.

Despite these positive clinical developments, Amgen and Viking Therapeutics have performed poorly on the stock market in the past 12 months, though progress in this area might eventually help them ...

Germany's Union Investment has dropped French oil major TotalEnergies from its sustainability funds and called for an ...

Venture Global is poised to become the largest U.S. liquefied natural gas company by next year if it proceeds with its CP2 ...

After the big “Liberation Day” selloff on April 3, I made a bold prediction. I told everyone that we would see a huge rally soon – we just needed to wait for the dust to settle first. And that’s ...